AbbVie Q3 Earnings Preview: R&D charge impact, pipeline progress in focus

AbbVie (ABBV) is scheduled to announce Q3 earnings results on Friday, October 31st, before market open.

The consensus EPS Estimate is $1.78 (-40.7% Y/Y) and the consensus revenue estimate is $15.59B (+7.8% Y/Y).

Over the last 2 years, ABBV has

Leave a Reply

Your email address will not be published. Required fields are marked *